Correction to "Retrospective analysis of cutaneous immune-related adverse events following checkpoint inhibitor therapy in melanoma patients reveals increased risk associated with the HLA-B*51:01 allele".
0/5 보강
APA
(2026). Correction to "Retrospective analysis of cutaneous immune-related adverse events following checkpoint inhibitor therapy in melanoma patients reveals increased risk associated with the HLA-B*51:01 allele".. Cancer, 132(6), e70350. https://doi.org/10.1002/cncr.70350
MLA
. "Correction to "Retrospective analysis of cutaneous immune-related adverse events following checkpoint inhibitor therapy in melanoma patients reveals increased risk associated with the HLA-B*51:01 allele".." Cancer, vol. 132, no. 6, 2026, pp. e70350.
PMID
41855079